The deubiquitinase USP4 stabilizes the SCF^FBXO24 ubiquitin E3 ligase to regulate immunity in experimental pneumonia.

Authors

Ilknur Yurtsever, Daniela Farkas, Alex Cornwell, Jessica A Joseph, Siying Xu, Joshua A Englert, Joseph S Bednash, James D Londino, Benjamin S Johnson, Rama K Mallampalli

Published in

Nature communications. Volume 17. Issue 1. Jul 22, 2026. Epub Jul 22, 2026.

Abstract

The ubiquitin E3 ligase SCF^FBXO24 targets key proteins for degradation that regulate important biological processes, but the mechanisms controlling cellular concentrations of its receptor subunit, F-box only protein 24 (FBXO24), remain unknown. Here, Haemophilus influenzae type B (HiB), an important cause of pneumonia, protects FBXO24 from lysosomal degradation in THP-1 macrophage cells by reducing its ubiquitylation levels. We identified that the ubiquitin-specific peptidase 4 (USP4) mediates FBXO24 deubiquitylation and stabilization in response to HiB infection in a TLR4 receptor-dependent manner. In experimental HiB pneumonia, either nanoparticle delivery of encapsulated USP4 siRNA or targeted genetic disruption of Fbxo24 in mice led to increased alveolar mononuclear cells coupled with reduced bacterial loads, attenuated pulmonary edema and decreased lung injury severity compared to control mice. Collectively, these findings demonstrate the ability of a bacterial pathogen to exploit a deubiquitylation mechanism to preserve cellular levels of an E3 ligase component, thereby impairing innate host defense responses.

PMID:
42552308
Bibliographic data and abstract were imported from PubMed on 05 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.